Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Regulation of p53 stability

Oncogene volume 18, pages 7637–7643 (1999)Cite this article

Abstract

Leading the way in imposing a policy of zero tolerance of cellular abnormalities that might lead to tumor development is the p53 protein. The efficiency of p53 in preventing cell growth is a strong deterrent to malignant progression, but this activity must be kept tightly restrained to allow normal cell growth and development. Essential components of this regulation are the mechanisms by which the p53 protein is degraded, and efficient turnover of p53 in normal cells prevents the accumulation of the protein. Modulation of these degradation pathways in response to stress leads to the rapid stabilization and accumulation of p53, and activation of the p53 response. It is now becoming clear that the Mdm2 protein is central to the regulation of p53 stability and multiple pathways exist through which the activity of Mdm2 can be inhibited. Defects in the ability to stabilize p53 are likely to contribute to malignant development, and restoration of this activity represents an extremely attractive possibility for tumor therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Arriola EL, Rodriguez Lopez A and Chresta CM. . 1999 Oncogene 18: 1081–1091.

  • Ashcroft M, Kubbutat MH and Vousden KH. . 1999 Mol. Cell. Biol. 19: 1751–1758.

  • Attardi LD and Jacks T. . 1999 Cell. Mol. Life Sci. 55: 48–63.

  • Balint E and Vousden KH. . 1999 Oncogene In press.

  • Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y. . 1998 Science 281: 1674–1677.

  • Bates S, Phillips AC, Clarke PA, Stott F, Peters G, Ludwig RL and Vousden KH. . 1998 Nature 395: 124–125.

  • Bates S and Vousden KH. . 1996 Curr. Opin. Genet. Dev. 6: 1–7.

  • Beer-Romero P, Glass S and Rolfe M. . 1997 Oncogene 14: 595–602.

  • Blattner C, Sparks A and Lane D. . 1999 Mol. Cell. Biol. 19: 3704–3713.

  • Böttger A, Böttger V, Sparks A, Liu W-L, Howard SF and Lane DP. . 1997 Curr. Biol. 7: 860–869.

  • Böttger V, Böttger A, Garcia-Echeverria C, Ramos YF, van der Eb AJ, Jochemsen AG and Lane DP. . 1999 Oncogene 18: 189–199.

  • Brown LR, Thomas CA and Deb SP. . 1998 EMBO J. 17: 2513–2525.

  • Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD. . 1998 Science 281: 1677–1679.

  • Chen L, Lu W, Agrawal S, Zhou W, Zhang R and Chen J. . 1999 Mol. Med. 5: 21–34.

  • Choi J and Donehower LA. . 1999 Cell. Mol. Life Sci. 55: 38–47.

  • Cuddihy AR, Li S, Tam NWN, Wong AH-T, Taya Y, Abraham N, Bell JC and Koromilas AE. . 1999 Mol. Cell. Biol. 19: 2475–248.

  • de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. . 1998 Genes Dev. 12: 2434–2442.

  • Dyson N. . 1998 Genes Dev. 12: 2245–2262.

  • Evans SC and Lozano G. . 1997 Mol. Med. Today 3: 390–395.

  • Freedman DA and Levine AJ. . 1998 Mol. Cell. Biol. 18: 7288–7293.

  • Fuchs SY, Adler V, Bushmann T, Yin Z, Wu X, Jones SN and Ronai Z. . 1998a Genes Develop. 12: 2658–2663.

  • Fuchs SY, Adler V, Pincus MR and Ronai Z. . 1998b Proc. Natl. Acad. Sci. USA 95: 10541–10546.

  • Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Ziao ZX, Kumar S, Howley PM and Livingston DM. . 1998 Mol. Cell. 2: 405–415.

  • Hall M and Peters G. . 1996 Adv. Cancer Res. 68: 67–108.

  • Haupt Y, Maya R, Kazaz A and Oren M. . 1997 Nature 387: 296–299.

  • Honda R, Tanaka H and Yasuda H. . 1997 FEBS Lett. 420: 25–27.

  • Honda R and Yasuda H. . 1999 EMBO J. 18: 22–27.

  • Hsieh JK, Chan FS, O'Connor DJ, Mittnacht S, Zhong S and Lu X. . 1999 Mol. Cell. 3: 181–193.

  • Jayaraman L and Prives C. . 1999 Cell. Mol. Life Sci. 55: 76–87.

  • Jones SN, Hancock AR, Vogel H, Donehower LA and Bradley A. . 1998 Proc. Natl. Acad. Sci. USA 95: 15608–15612.

  • Jones SN, Roe AE, Donehower LA and Bradley A. . 1995 Nature 378: 206–208.

  • Juven-Gershon T, Shifman O, Unger T, Elkeles A, Haupt Y and Oren M. . 1998 Mol. Cell Biol. 18: 3974–3982.

  • Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 8292–8297.

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. . 1997 Cell 91: 649–659.

  • Kastan MB, Zhan Q, El Deiry W-S, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr A-J. . 1992 Cell 71: 587–597.

  • Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP and Lavin MF. . 1998 Nat. Genet. 20: 398–400.

  • Kraus A, Neff F, Behn M, Schuermann M, Muenkel K and Schlegel J. . 1999 Int. J. Cancer 80: 930–934.

  • Kubbutat MHG, Ludwig RL, Ashcroft M and Vousden KH. . 1998 Mol. Cell. Biol. 18: 5690–5698.

  • Kubbutat MHG, Ludwig RL, Levine AJ and Vousden KH. . 1999 Cell Growth Diff. 10: 87–92.

  • Kubbutat MHG and Vousden KH. . 1997 Mol. Cell. Biol. 17: 460–468.

  • Kubbutat MHG and Vousden KH. . 1998 Mol. Med. Today 4: 250–256.

  • Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ and Pavletich NP. . 1996 Science 274: 948–953.

  • Lain S, Midgley C, Sparks A, Lane EB and Lane DP. . 1999 Exp. Cell Res. 248: 457–472.

  • Léveillard T and Wasylyk B. . 1997 J. Biol. Chem. 272: 30651–30661.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD and Berger SL. . 1999 Mol. Cell Biol. 19: 1202–1209.

  • Lu X and Lane DP. . 1993 Cell 75: 765–778.

  • Lundgren K, Montes de Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP and Finlay CA. . 1997 Genes Dev. 11: 714–725.

  • Marechal V, Elenbaas B, Piette J, Nicolas J-C and Levine AJ. . 1994 Mol. Cell. Biol. 14: 7414–7420.

  • Marston NJ, Crook T and Vousden KH. . 1994 Oncogene 9: 2707–2716.

  • Martin K, Trouche D, Hagemeier C, Sørensen TS, La Thangue NB and Kouzarides T. . 1995 Nature 375: 691–694.

  • Mayo LD, Turchi JJ and Berberich SJ. . 1997 Cancer Res. 57: 5013–5016.

  • Meek DW. . 1998 Cell Signal. 10: 159–166.

  • Midgley CA and Lane DP. . 1997 Oncogene 15: 1179–1189.

  • Moll UM, Ostermeyer A, Haladay R, Winkfield B, Frazier M and Zambetti G. . 1996 Mol. Cell. Biol. 16: 1126–1137.

  • Momand J, Zambetti GP, George DL and Levine AJ. . 1992 Cell 69: 1237–1245.

  • Montes de Oca Luna R, Wagner DS and Lozano G. . 1995 Nature 378: 203–206.

  • Nakagawa K, Taya Y, Tamai K and Yamaizumi M. . 1999 Mol. Cell. Biol. 19: 2828–2834.

  • Nevins JR. . 1998 Cell Growth Differ. 9: 585–593.

  • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. . 1993 Nature 362: 857–860.

  • Palmero I, Pantoja C and Serrano M. . 1998 Nature 395: 125–126.

  • Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L and Van Dyke T. . 1998 Mol. Cell 2: 238–292.

  • Pariat M, Carillo S, Molinari M, Salvat C, Debussche L, Bracco L, Milner J and Piechaczyk M. . 1997 Mol. Cell. Biol. 17: 2806–2815.

  • Pietenpol JA and Vogelstein B. . 1993 Nature 365: 17–18.

  • Pomerantz J, Schreiber-Agus N, Liégeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Cordon-Cardo C and DePinho RA. . 1998 Cell 92: 713–723.

  • Reinke V and Lozano G. . 1997 Oncogene 15: 1527–1534.

  • Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ. . 1998 EMBO J. 17: 554–564.

  • Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW and Appella E. . 1998 Genes Dev. 12: 2831–2841.

  • Scheffner M, Huibregtse JM, Vierstra RD and Howley PM. . 1993 Cell 75: 495–505.

  • Sherr CJ. . 1998 Genes Dev. 12: 2984–2991.

  • Shieh S-Y, Ikeda M, Taya Y and Prives C. . 1997 Cell 91: 325–334.

  • Shieh SY, Taya Y and Prives C. . 1999 EMBO J. 18: 1815–1823.

  • Sigalas I, Calvert AH, Anderson JJ, Neal DE and Lunec J. . 1996 Nature Med. 2: 912–917.

  • Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E and Kastan MB. . 1997 Genes Dev. 11: 3471–3481.

  • Sionov RV, Moallem E, Berger M, Kazaz A, Gerlitz O, Ben-Neriah Y, Oren M and Haupt Y. . 1999 J. Biol. Chem. 274: 8371–8374.

  • Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ and Wahl GM. . 1999 EMBO J. 18: 1660–1672.

  • Stott F, Bates SA, James M, McConnell BB, Starborg M, Brookes S, Palmero I, Hara E, Ryan KM, Vousden KH and Peters G. . 1998 EMBO J. 17: 5001–5014.

  • Sun P, Dong P, Dai K, Hannon GJ and Beach D. . 1998 Science 282: 2270–2272.

  • Talis AL, Huibregtse JM and Howley PM. . 1998 J. Biol. Chem. 273: 6439–6445.

  • Tao W and Levine AJ. . 1999 Proc. Natl. Acad. Sci. USA 96: 3077–3080.

  • Thomas A and White E. . 1998 Genes Dev. 12: 1975–1985.

  • Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C and Abraham RT. . 1999 Genes Dev. 13: 152–157.

  • Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L and Jacks T. . 1998 Mol. Cell. 2.

  • Tyler M and Willems AR. . 1999 Science 284: 601–604.

  • Unger T, Juven-Gershon T, Moallem E, Berger M, Vogt Sionov R, Lozano G, Oren M and Haupt Y. . 1999 EMBO J. 18: 1805–1814.

  • Varshavsky A. . 1997 TIBS 22: 383–387.

  • Weber JD, Taylor LJ, Roussel MF, Sherr CJ and Bar-Sagi D. . 1999 Nature Cell Biol. 1: 20–26.

  • Xiao Z-X, Chen J, Levine A, Modjtahedi N, Xing J, Sellers WR and Livingston DM. . 1995 Nature 375: 694–697.

  • Yuan ZM, Huang Y, Ishiko T, Nakada S, Utsugisawa T, Shioya H, Utsugisawa Y, Yokoyama K, Weichselbaum R, Shi Y and Kufe D. . 1999 J. Biol. Chem. 274: 1883–1886.

  • Zhang X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin WGJ, Oren M, Chen J and Lu H. . 1999 Mol. Cell Biol. 19: 3257–3266.

  • Zhang W, Lu Q, Xie Z-J and Mellgren RL. . 1997 Oncogene 14: 255–263.

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. . 1998 Genes Dev. 12: 2424–2433.

Download references

Acknowledgements

We are grateful to members of the Vousden lab for advice and helpful criticisms of this review. This work was sponsored by the National Cancer Institute, DHHS, under contract with ABL.

Author information

Authors and Affiliations

  1. ABL Basic Research Program, NCI-FCRDC, Building 560, Room 22-96, West 7th Street, Frederick, 21702, Maryland, MD, USA

    Margaret Ashcroft & Karen H Vousden

Authors
  1. Margaret Ashcroft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen H Vousden
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ashcroft, M., Vousden, K. Regulation of p53 stability. Oncogene 18, 7637–7643 (1999). https://doi.org/10.1038/sj.onc.1203012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203012

Keywords

This article is cited by

Search

Advanced search

Quick links